The beneficial effects of postconditioning on no-reflow phenomenon after percutaneous coronary intervention in patients with ST-elevation acute myocardial infarction

被引:31
作者
Dong, Mei [1 ]
Mu, Nan [2 ]
Guo, Fangming [3 ]
Zhang, Chuanhuan [1 ]
Ren, Faxin [1 ]
Li, Jianping [1 ]
Tao, Zhigang [1 ]
Yang, Jun [1 ]
Li, Guangping [4 ]
机构
[1] Yuhuangding Hosp, Dept Cardiol, Yantai 264000, Shandong, Peoples R China
[2] Yuhuangding Hosp, Dept Gynecol, Yantai 264000, Shandong, Peoples R China
[3] Yantaishan Hosp, Dept Cardiol, Yantai 264001, Shandong, Peoples R China
[4] Tianjin Med Univ, Hosp 2, Dept Cardiol, Tianjin Inst Cardiol, Tianjin 300211, Peoples R China
关键词
Postconditioning; No-reflow phenomenon; Percutaneous coronary intervention; Inflammation; ISCHEMIA-REPERFUSION INJURY; C-REACTIVE PROTEIN; CONTRAST ECHOCARDIOGRAPHY; PROGNOSTIC VALUE; SIZE; RISK; ANGIOPLASTY; OCCLUSIONS; REDUCTION; PREDICTOR;
D O I
10.1007/s11239-013-1010-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
No-reflow phenomenon is a serious complication of percutaneous coronary intervention (PCI) which is closely related to the incidence of major adverse cardiovascular events. It has been demonstrated that Postconditioning (PostC) during primary PCI confers protection against ischemia-reperfusion injury and thus might reduce infarct size. However, whether PostC may exert its beneficial effects on acute myocardial infarction (AMI) patients by reducing no-reflow phenomenon is still unknown. Sixty two patients diagnosed with ST-elevation AMI were randomly assigned to study group (n = 32) or control group (n = 30). Blood samples were obtained and assayed for creatine kinase MB (CK-MB) and high-sensitive C-reactive protein (hs-CRP). Determinants of reflow, including final thrombolysis in myocardial infarction (TIMI) grade-3 flow, ST-segment resolution (STR), myocardial blush grades-3 (MBG-3) and corrected thrombolysis in myocardial infarction frame count (cTFC), were comparative between the two groups. Compared with control group, more patients in study group were identified as the final TIMI grade-3 flow (81.3 vs. 56.7 %, P = 0.036), MBG-3 (23 vs. 14 %, P = 0.043) and STR >= 50 % (93.8 vs. 73.3 %, P = 0.029), while patients in study group had less cTFC (28.5 +/- 9.1 vs. 37.4 +/- 12.4, P = 0.002) After PCI, study group was associated with lower levels of CK-MB (2,397.6 +/- 470.2 vs. 2,159.9 +/- 485.5, P = 0.028), Troponin-I (197.5 +/- 32.5 vs. 154 +/- 43.1, P = 0.041) and hsCRP (5.5 +/- 4.5 vs. 9.5 +/- 5.2 mg/L, P = 0.019) in comparison with control group. Left ventricle ejection fraction was better in the study group than in the control group (55.1 +/- 9.8 vs. 42.9 +/- 10.7, P = 0.042). PostC could improve myocardial reperfusion in patients with ST-elevation AMI undergoing PCI by reducing no-reflow. However, due to the limited sample size, the results of our study should not be considered conclusive.
引用
收藏
页码:208 / 214
页数:7
相关论文
共 36 条
[1]   Electrocardiographic identification of the culprit coronary artery in inferior wall ST elevation myocardial infarction [J].
Almansori, Mohammed ;
Armstrong, Paul W. ;
Fu, Yuling ;
Kaul, Padma .
CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 (06) :293-296
[2]   Standardised pre-hospital care of acute myocardial infarction patients: MISSION! guidelines applied in practice [J].
Atary, J. Z. ;
de Visser, M. ;
van den Dijk, R. ;
Bosch, J. ;
Liem, S. S. ;
Antoni, M. L. ;
Bootsma, M. ;
Viergever, E. P. ;
Kirchhof, C. J. ;
Padmos, I. ;
Sedney, M. I. ;
van Exel, H. J. ;
Verwey, H. F. ;
Atsma, D. E. ;
van der Wall, E. E. ;
Jukema, J. W. ;
Schalij, M. J. .
NETHERLANDS HEART JOURNAL, 2010, 18 (09) :408-415
[3]   MYOCARDIAL REPERFUSION, LIMITATION OF INFARCT SIZE, REDUCTION OF LEFT-VENTRICULAR DYSFUNCTION, AND IMPROVED SURVIVAL - SHOULD THE PARADIGM BE EXPANDED [J].
BRAUNWALD, E .
CIRCULATION, 1989, 79 (02) :441-444
[4]   MYOCARDIAL REPERFUSION - A DOUBLE-EDGED SWORD [J].
BRAUNWALD, E ;
KLONER, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (05) :1713-1719
[5]   Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention [J].
Chew, DP ;
Bhatt, DL ;
Robbins, MA ;
Penn, MS ;
Schneider, JP ;
Lauer, MS ;
Topol, EJ ;
Ellis, SG .
CIRCULATION, 2001, 104 (09) :992-997
[6]   Utility of Cardiac Biomarkers in Predicting Infarct Size, Left Ventricular Function, and Clinical Outcome After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction [J].
Chia, Stanley ;
Senatore, Fred ;
Raffel, O. Christopher ;
Lee, Hang ;
Wackers, Frans J. Th. ;
Jang, Ik-Kyung .
JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (04) :415-423
[7]  
Couvreur N, 2008, AM J PHYSIOL-HEART C, V291, pH1345
[8]   Reduction of Delays in Primary Percutaneous Coronary Intervention [J].
Daneault, Benoit ;
Doan Hoa Do ;
Maltais, Andree ;
Berube, Simon ;
Harvey, Richard ;
Gervais, Andre ;
Dalery, Karl ;
Nguyen, Michel .
CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (05) :562-566
[9]  
Kaufmann PA, 2005, J NUCL MED, V46, P75
[10]   Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials [J].
Keeley, EC ;
Boura, JA ;
Grines, CL .
LANCET, 2003, 361 (9351) :13-20